Dx dialogues: identifying patients with cutaneous melanoma for TIL therapy
Dx dialogues: exciting advancements in development for the treatment of cutaneous melanoma
Dx dialogues: a potential paradigm shift in the treatment of metastatic breast cancer
Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Dx dialogues: changes in treatment sequencing for metastatic breast cancer
Dx dialogues: versatile treatment options across the multiple myeloma landscape
Dx dialogues: how AI might be used in the R/R AML space
Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML
Dx dialogues: the impact of next-generation sequencing on clinical utility
Dx dialogues: the importance of comprehensive testing in oncology
Desmoid tumors are noncancerous and do not metastasize, but they can invade nearby tissues and structures.
Although it’s not the most common cancer, it is among the most deadly. Here’s why—and why there’s hope for future treatments.
Why monitoring and managing protein levels in the urine is a focus of treatment for this rare kidney disease.
What to ask your healthcare providers when discussing treatment for nasal polyps, including medications and surgery.
An overview of early-stage and late-stage diabetic retinopathy, with a look at diabetic macular edema.